CCL5 and neoplasm: Inside the TME, Prostaglandin E2 (PGE2) inhibits CCL5 and XCL1 production and leads to reduced NK cell viability, highlighting that the TME can interfere with NK cell-mediated anti-tumor functions through multiple mechanisms [65].